InvestorsHub Logo
Followers 1
Posts 75
Boards Moderated 0
Alias Born 03/20/2018

Re: None

Wednesday, 10/26/2022 10:51:28 AM

Wednesday, October 26, 2022 10:51:28 AM

Post# of 34600
Tax sales

Everyone here, or almost everyone, I have to assume has a losing position on this stock. I don't believe it will go anywhere but some pump and dumps for the company to issue more equity.
Certainly nothing big happening in the next 30 days.

You should all sell for the tax loss and then re-assess whether or not to buy back in 31 days later. I bet most of you will decide that there is a better use for that cash than this stock and it will free you from this constant waiting and slow death of its value.

The tobacco study doesn't matter much, ON! and Zyn have the market outside of the traditional dips and side effects aren't bad enough for people to care about dehydratech,

The epilepsy study is also fairly hopeless. Epiliodex is already on pace to be a $1bn drug in the next couple of years and the amount of money it would take to crack that market and take share is far more than LEXX will ever have. Commercialization is insanely expensive. They also would have to be significantly better in order to win approval or show much better in the side effects department. I don't think that one has legs. Their tech has more to do with absorption speeds than anything else and epiliodex is a daily medicine not an as needed medicine, so speed isn't important.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News